Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-10-03 Sale |
2022-10-03 8:25 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease |
14,226 | $148.5 | $2,112,561 | 0 (Direct) |
View |
| 2020-11-02 Sale |
2020-11-04 8:31 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease |
30,000 | $76.22 | $2,286,676 | 51,755 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-09 Option Award |
2025-01-10 6:02 pm |
N/A 2035-01-09 |
Annexon Inc. | ANNX | JONES WILLIAM A JR Director |
88,000 | $0 | 88,000 (Direct) |
View |
| 2025-01-07 Option Award |
2025-01-07 5:12 pm |
N/A N/A |
NewAmsterdam Pharma Co N.V. | NAMS | JONES WILLIAM A JR Chief Commercial Officer |
43,000 | $0 | 43,000 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 5:51 pm |
N/A 2035-01-02 |
NewAmsterdam Pharma Co N.V. | NAMS | JONES WILLIAM A JR Chief Commercial Officer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 8:12 pm |
N/A 2034-06-05 |
Apogee Therapeutics Inc. | APGE | JONES WILLIAM A JR Director |
10,370 | $0 | 10,370 (Direct) |
View |
Ownership |
2024-05-03 4:15 pm |
N/A 2033-08-14 |
NewAmsterdam Pharma Co N.V. | NAMS | JONES WILLIAM A JR Chief Commercial Officer |
0 | $0 | 945,598 (Direct) |
View |
Ownership(A) |
2023-07-17 4:59 pm |
N/A N/A |
Apogee Therapeutics Inc. | APGE | JONES WILLIAM A JR Director |
0 | $0 | 34,824 (Direct) |
View |
Ownership |
2023-07-13 6:40 pm |
N/A N/A |
Apogee Therapeutics Inc. | APGE | JONES WILLIAM A JR Director |
0 | $0 | 30,187 (Direct) |
View |
| 2023-05-02 Option Award |
2023-05-04 4:20 pm |
N/A 2033-05-02 |
Akili Inc. | AKLI | JONES WILLIAM A JR Director |
22,000 | $0 | 22,000 (Direct) |
View |
| 2022-11-02 Option Award |
2022-11-04 6:58 pm |
N/A 2032-11-02 |
Akili Inc. | AKLI | JONES WILLIAM A JR Director |
44,000 | $0 | 44,000 (Direct) |
View |
| 2022-01-07 Option Award |
2022-01-07 9:16 pm |
N/A 2032-01-07 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease |
45,000 | $0 | 80,249 (Direct) |
View |
| 2022-01-07 Tax Withholding |
2022-01-07 9:16 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease |
1,631 | $128.87 | 80,249 (Direct) |
View |
| 2022-01-06 Exercise |
2022-01-07 9:16 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease |
8,750 | $0 | 80,249 (Direct) |
View |
| 2022-01-06 Tax Withholding |
2022-01-07 9:16 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease |
2,230 | $123.86 | 80,249 (Direct) |
View |
| 2021-11-25 Exercise |
2021-11-26 4:32 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease |
3,000 | $0 | 11,822 (Direct) |
View |
| 2021-11-25 Tax Withholding |
2021-11-26 4:32 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease |
1,305 | $115.55 | 11,822 (Direct) |
View |
| 2021-01-06 Tax Withholding |
2021-01-08 8:49 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease |
2,124 | $83.38 | 82,127 (Direct) |
View |
| 2021-01-06 Option Award |
2021-01-08 8:49 pm |
N/A 2031-01-06 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease |
60,000 | $0 | 82,127 (Direct) |
View |
| 2021-01-06 Exercise |
2021-01-08 8:49 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease |
5,000 | $0 | 82,127 (Direct) |
View |
| 2020-11-25 Tax Withholding |
2020-11-27 9:48 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease |
1,245 | $90.14 | 9,510 (Direct) |
View |
| 2020-11-25 Exercise |
2020-11-27 9:48 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease |
3,000 | $0 | 9,510 (Direct) |
View |
| 2020-11-02 Exercise |
2020-11-04 8:31 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease |
30,000 | $50.72 | 51,755 (Direct) |
View |
| 2020-11-02 Exercise |
2020-11-04 8:31 pm |
N/A 2029-03-31 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease |
30,000 | $0 | 51,755 (Direct) |
View |